Cargando…
Nanocarrier-based immunotherapy in cancer management and research
Research in cancer immunotherapy has gained momentum in the last two decades, with many studies and clinical trials showing positive therapeutic outcomes. Immunotherapy can elicit not only a strong anticancer immune response which could even control metastases, but could also induce immunological me...
Autores principales: | Singh, Manu Smriti, Bhaskar, Sangeeta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918240/ https://www.ncbi.nlm.nih.gov/pubmed/27471704 http://dx.doi.org/10.2147/ITT.S62471 |
Ejemplares similares
-
Tumor Targeted Nanocarriers for Immunotherapy
por: Baeza, Alejandro
Publicado: (2020) -
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
por: Liu, Luman, et al.
Publicado: (2022) -
Nanocarriers for cancer nano-immunotherapy
por: Rana, Isra, et al.
Publicado: (2022) -
Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery
por: Fuchs, Natalie, et al.
Publicado: (2020) -
Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy
por: Baker, Abu, et al.
Publicado: (2023)